Customer Services

Helix BioMedix, Inc. - Pharmaceuticals & Healthcare

Deals and Alliances Profile

Product Code GMD12451
Publication Date July 2009
Publisher Global Markets Direct
Product Type Report
Pages 22
Buy this product or for assistance call +44 20 7060 7474
PDF £165.00$250 | €184
FAX Order above formats by FAX

Helix BioMedix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Helix BioMedix, Inc. is a biopharmaceutical company, engaged in development of short, small-chain peptides with anti-infective, anti-inflammatory properties, such as the stimulation of cell proliferation and migration. These peptides are used as ingredients in cosmetics and topical therapeutics. The applications include anti-aging skin care, acne treatment, wound healing and the treatment of fungal dermatoses. It has developed numerous peptide sequences in skin care and pharmaceutical application areas. The company is headquartered at Bothell in Washington, United States

Global Market Direct's Helix BioMedix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.

Scope

  • Provides key company information for business intelligence needs
  • Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

  • A quick ""one-stop-shop"" to understand the company.
  • Support sales activities by understanding your customers' businesses.
  • Qualify prospective partners and suppliers.
  • Understand and respond to your competitors' business structure, strategy and prospects through.
  • Understanding the key deals which have shaped the company.
Table Of Contents Table Of Contents 2 List of Tables 3 List of Figures 3 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Helix BioMedix, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deal Details 9 Helix BioMedix Issues Convertible Notes For $3.24 Million 9 Helix BioMedix Issues Convertible Notes For $3 Million 10 Equity Offering 11 Helix BioMedix Completes Private Placement Of $2.6 Million 11 Helix BioMedix Completes Private Placement Of $2.5 Million 12 Helix BioMedix Completes Private Placement Of $2.37 Million 13 Partnerships 14 Helix BioMedix Signs Licensing Agreement With Rodan & Fields 14 Helix BioMedix Amends Its Licensing Agreement With Grant Industries 15 Helix BioMedix Signs Agreement With Goldschmidt 16 Helix BioMedix Enters Into Licensing Agreement With Levlad 17 Helix BioMedix Signs Licensing Agreement With American Global Health Group 18 Helix BioMedix Signs Agreement With Smith & Nephew 19 Helix BioMedix Signs Agreement With Body Blue 20 Key Competitors 21 Key Employees 21 Locations And Subsidiaries 21 Head Office 21 Appendix 22 Methodology 22 About Global Markets Direct 22 Contact Us 22 Disclaimer 22 List of Tables Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Helix BioMedix, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Helix BioMedix, Inc., Deals By Sector, 2004 to YTD 2009 7 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8 Helix BioMedix Issues Convertible Notes For $3.24 Million 9 Helix BioMedix Issues Convertible Notes For $3 Million 10 Helix BioMedix Completes Private Placement Of $2.6 Million 11 Helix BioMedix Completes Private Placement Of $2.5 Million 12 Helix BioMedix Completes Private Placement Of $2.37 Million 13 Helix BioMedix Signs Licensing Agreement With Rodan & Fields 14 Helix BioMedix Amends Its Licensing Agreement With Grant Industries 15 Helix BioMedix Signs Agreement With Goldschmidt 16 Helix BioMedix Enters Into Licensing Agreement With Levlad 17 Helix BioMedix Signs Licensing Agreement With American Global Health Group 18 Helix BioMedix Signs Agreement With Smith & Nephew 19 Helix BioMedix Signs Agreement With Body Blue 20 Helix BioMedix, Inc., Key Employees 21 List of Figures Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6 Helix BioMedix, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7
Back to top

Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Actions

© 2010 | Report Buyer is a trading name for Piribo Ltd. Registered in England and Wales No. 05051530 | VAT Reg No. GB 839 4556 85

comodo ev ssl site
Internet shopping is safe
SecurityMetrics for PCI Compliance, QSA, IDS, Penetration Testing, Forensics, and Vulnerability Assessment